2026 Summer Intern – Health Economics & Outcomes Research at Acadia Pharmaceuticals

Parsippany, New Jersey, United States

Apply Now

Not SpecifiedCompensation

InternshipExperience Level

InternshipJob Type

UnknownVisa

Biopharmaceutical, PharmaceuticalIndustries

Requirements

Working towards a PharmD (year 3 or above), MPH, MBA, or PhD degree with interest in HEOR, Market Access, and the pharmaceutical industry
Basic understanding of economic modeling
Intermediate experience with Microsoft Office Suite (Excel, PowerPoint, Word)
Basic understanding of the US healthcare system (including payers, PBMs, health systems/hospitals, pharma, regulators)
Analytical and curious mindset
For Parsippany-based roles: Work no less than 4 days at the site in Parsippany, New Jersey, with potential for 1 day remote per week
Ability to complete the entire 10-week program (May 26, 2026 to July 31, 2026) at 37.5 hours per week
Cumulative 3.0 GPA or above (college transcript required; must mail official transcript by application deadline)
Currently enrolled in an accredited U.S.-based college or university (undergraduate Bachelor's, graduate, MBA, JD, PharmD, or PhD program)
Legally authorized to work in the U.S. without need for sponsorship/CPT/OPT now or in the future
At least 18 years of age prior to start date
Available for virtual interviews with HR and hiring manager
Successfully pass drug screen and background check prior to start date
Complete a final presentation at the end of the 10-week program (mandatory)
Application by January 9, 2026 deadline

Responsibilities

Support development, update, or adapt an economic model or replicate an economic model
Evaluate current HEOR strategy for 1 brand (uro-oncology or orthopaedics)
Propose new HEOR projects aligned with medical and commercial strategies
Conduct targeted literature reviews for uro-oncology or orthopaedics (Patient reported outcomes or clinical trials or real world studies)
Host journal club of 1 or more HEOR studies of the intern's choosing

Skills

Key technologies and capabilities for this role

HEOREconomic ModelingLiterature ReviewMicrosoft ExcelMicrosoft PowerPointUS Healthcare SystemMarket Access

Questions & Answers

Common questions about this position

What is the work location and remote policy for this internship?

This role is based in Parsippany, New Jersey, requiring at least 4 days per week at the site, with the option to work 1 day per week remotely.

What are the educational requirements for this internship?

Candidates must be working towards a PharmD (year 3 or above), MPH, MBA, or PhD degree with interest in HEOR, Market Access, and the pharmaceutical industry, and currently enrolled in an accredited U.S. based college or university.

What skills and experience are required for this HEOR internship?

A basic understanding of economic modeling, intermediate experience with Microsoft Office Suite (Excel, PowerPoint, Word), and basic understanding of the US healthcare system are required, along with an analytical and curious mindset.

What is the duration and time commitment for the internship?

The internship is a 10-week full-time program from May 26, 2026 to July 31, 2026, requiring 37.5 hours per week.

What makes a strong application for this internship?

Strong candidates will have a cumulative 3.0 GPA or above with an official college transcript mailed by the application deadline, be legally authorized to work in the U.S. without sponsorship, and be at least 18 years old.

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters

1993Year Founded

$813.4MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.

Potential clinical trial delays could affect drug approval timelines.

Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.

The company has a strong R&D foundation, developing innovative small molecule drugs.

Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.

Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.

The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI

Try Jobo Free